Short Bowel Syndrome clinical trials at University of California Health
2 in progress, 0 open to eligible people
Showing trials for
Long-term Safety of Apraglutide in Short Bowel Syndrome.
Sorry, in progress, not accepting new patients
The primary objective of the trial is to assess long-term safety and tolerability of apraglutide in subjects with SBS-IF.
at UCLA
Apraglutide in SBS-IF
Sorry, in progress, not accepting new patients
The primary objective of the trial is the confirmation of the efficacy of apraglutide to evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support dependency.
at UCLA
Our lead scientists for Short Bowel Syndrome research studies include Robert Venick.
Last updated: